1. Home
  2. NBTX vs FSTR Comparison

NBTX vs FSTR Comparison

Compare NBTX & FSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • FSTR
  • Stock Information
  • Founded
  • NBTX 2003
  • FSTR 1902
  • Country
  • NBTX France
  • FSTR United States
  • Employees
  • NBTX N/A
  • FSTR N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • FSTR Metal Fabrications
  • Sector
  • NBTX Health Care
  • FSTR Industrials
  • Exchange
  • NBTX Nasdaq
  • FSTR Nasdaq
  • Market Cap
  • NBTX 201.9M
  • FSTR 213.5M
  • IPO Year
  • NBTX 2020
  • FSTR N/A
  • Fundamental
  • Price
  • NBTX $4.00
  • FSTR $23.68
  • Analyst Decision
  • NBTX Strong Buy
  • FSTR Hold
  • Analyst Count
  • NBTX 2
  • FSTR 1
  • Target Price
  • NBTX $11.50
  • FSTR $21.00
  • AVG Volume (30 Days)
  • NBTX 6.4K
  • FSTR 37.6K
  • Earning Date
  • NBTX 11-19-2024
  • FSTR 11-07-2024
  • Dividend Yield
  • NBTX N/A
  • FSTR N/A
  • EPS Growth
  • NBTX N/A
  • FSTR N/A
  • EPS
  • NBTX N/A
  • FSTR 3.85
  • Revenue
  • NBTX $45,220,186.00
  • FSTR $537,459,000.00
  • Revenue This Year
  • NBTX N/A
  • FSTR $1.47
  • Revenue Next Year
  • NBTX N/A
  • FSTR $7.63
  • P/E Ratio
  • NBTX N/A
  • FSTR $6.29
  • Revenue Growth
  • NBTX 526.17
  • FSTR N/A
  • 52 Week Low
  • NBTX $4.04
  • FSTR $14.23
  • 52 Week High
  • NBTX $8.96
  • FSTR $30.77
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 37.42
  • FSTR 74.59
  • Support Level
  • NBTX $4.07
  • FSTR $20.16
  • Resistance Level
  • NBTX $4.44
  • FSTR $24.30
  • Average True Range (ATR)
  • NBTX 0.21
  • FSTR 0.81
  • MACD
  • NBTX -0.03
  • FSTR 0.51
  • Stochastic Oscillator
  • NBTX 0.00
  • FSTR 97.47

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About FSTR L.B. Foster Company

L.B. Foster Co is a us-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through three segments: Rail Technologies and Services; Precast Concrete Products and Steel Products and Measurement. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.

Share on Social Networks: